Literature DB >> 27799629

Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI.

Anderson Sanches de Melo1, Jhenifer Kliemchen2, Alceu Afonso Jordão Junior3, Rui A Ferriani4, Paula Andrea Navarro5.   

Abstract

Oxidative stress (OS) may affect natural fertility and the results of assisted reproduction techniques (ARTs). Subfertility associated with polycystic ovary syndrome (PCOS) may be related to OS. This process may intensify during controlled ovarian stimulation (COS) for ARTs because of increased ovarian metabolic activity and hypoestrogenism with the use of gonadotropin-releasing hormone agonists (GnRHas). The objective of this study was to investigate the presence of systemic OS in non-stimulated cycles and to determine OS markers (malondialdehyde [MDA], advanced oxidation protein products [AOPP], hydroperoxides [FOX], glutathione [GSH], and vitamin E) during COS in non-obese infertile women with and without PCOS who were subjected to ARTs. A prospective cohort study was conducted on non-obese women (16 with PCOS, and 60 ovulatory patients with infertility due to male and/or tubal factors). The OS markers were determined during the following time-points: the follicular phase of the natural cycle (D1), after pituitary downregulation with GnRHa and before the use of gonadotropins (D2), on the day of administration of human chorionic gonadotropin (D3), and at oocyte retrieval (D4). Intergroup analysis showed that serum MDA concentrations were higher in the PCOS group at D3 (P=0.048) and D4 (P=0.002). On an intragroup analysis, the control group had higher MDA concentrations at D2 than at D1 (P=0.01) or D4 (P=0.004). The AOPP concentrations were higher at D2 (P<0.0001), D3 (P<0.001) and D4 (P<0.0001) compared to D1. The FOX concentrations were lower at D2 (P<0.0001), D3 (P<0.0001), and D4 (P<0.001) than at D1. Serum GSH concentrations were significantly higher at D4 than at D1 (P=0.02). An intragroup analysis of the PCOS subjects showed that the five OS markers did not differ significantly among the four time-points when they were analyzed (D1, D2, D3 and D4). In conclusion, non-obese infertile women with PCOS showed evidence of systemic OS after COS with gonadotropins for ICSI. On the other hand, non-obese ovulatory infertile women, and women with infertility due to male and/or tubal factors showed a possible systemic oxidative balance until the final of COS.

Entities:  

Year:  2016        PMID: 27799629     DOI: 10.1530/REP-16-0084

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  5 in total

1.  Glutathione-dependent enzymes in the follicular fluid of the first-retrieved oocyte and their impact on oocyte and embryos in polycystic ovary syndrome: A cross-sectional study.

Authors:  Fatemeh Zal; Pardis Ahmadi; Maryam Davari; Fatemeh Khademi; Mojgan Akbarzadeh Jahromi; Zahra Anvar; Bahia Namavar Jahromi
Journal:  Int J Reprod Biomed       Date:  2020-06-30

2.  Single-cell analysis of differences in transcriptomic profiles of oocytes and cumulus cells at GV, MI, MII stages from PCOS patients.

Authors:  Qiwei Liu; Yumei Li; Yun Feng; Chaojie Liu; Jieliang Ma; Yifei Li; Huifen Xiang; Yazhong Ji; Yunxia Cao; Xiaowen Tong; Zhigang Xue
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

3.  Advanced Oxidative Protein Products Drive Trophoblast Cells Into Senescence by Inhibiting the Autophagy: The Potential Implication of Preeclampsia.

Authors:  Zhengjuan Li; Shuoshi Wang; Liping Li
Journal:  Front Cell Dev Biol       Date:  2022-03-09

4.  Single-Cell Transcriptomics of Human Oocytes: Environment-Driven Metabolic Competition and Compensatory Mechanisms During Oocyte Maturation.

Authors:  Hongcui Zhao; Tianjie Li; Yue Zhao; Tao Tan; Changyu Liu; Yali Liu; Liang Chang; Ning Huang; Chang Li; Yong Fan; Yang Yu; Rong Li; Jie Qiao
Journal:  Antioxid Redox Signal       Date:  2018-04-13       Impact factor: 8.401

5.  Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency.

Authors:  Xing-Yu Zhou; Jun Zhang; Ying Li; Ying-Xue Chen; Xiao-Min Wu; Xin Li; Xiao-Fei Zhang; Lin-Zi Ma; Yi-Zhen Yang; Ke-Ming Zheng; Yu-Dong Liu; Zhe Wang; Shi-Ling Chen
Journal:  Oxid Med Cell Longev       Date:  2021-07-27       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.